EU's faltering steps towards first approval of a combined ATMP: progress still slow
This article was originally published in Clinica
Executive Summary
The EU is seeing slow progress among companies coming forward to comply with its Advanced Therapy Medicinal Products Regulation which became fully mandatory at the end of last year.